New NICE guidance

NICE published several pieces of new guidance and appraisals in October, including a technology appraisal of liraglutide for the treatment of type 2 diabetes which recommends its use in both dual and triple therapy in some circumstances at a maximum daily dose of 1.2 mg but not 1.8 mg (see here for liraglutide details and here for a list of guidance by date).